Studies have shown that eating habits become easier to control when combined with sustained physical activity
Table 1: Adverse Reactions Reported in 1% and More Frequent in EGRIFTA?treated than Placebo Patients during the 26-Week Phase (Combined Studies) In the EGRIFTA clinical trials, mean baseline HbA1c was 5.3% among patients in both the EGRIFTA and placebo groups
Primary endpoint: 26% reduction in 3-point MACE (HR 0.74, 95% CI 0.58-0.95, p=0.02)
Pack Like a Pro: Travel Essentials for GLP-1 Users Heres what to include in your medication travel kit: A high-quality cooler or medical-grade travel case Frozen gel packs (TSA-compliant if flying) Extra needles, alcohol swabs, and your prescription label A digital thermometer to monitor temps Contact info for your pharmacy and provider Always store your compounded semaglutide or tirzepatide in its original packaging to protect it from light and ensure it's clearly labeled
Summary CLA is a naturally occurring fatty acid
Treatment typically begins with a low starter dose (0.25 mg weekly for 4 weeks), followed by gradual increases (0.5 mg, then up to 12 mg weekly for Ozempic, or up to 2.4 mg for Wegovy), depending on tolerability and clinical response
